Home › Trial NCT02375334
Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy
- Trial IDNCT02375334
- StatusTerminated
- PhaseN/A
- Study typeObservational
- SponsorWake Forest University Health Sciences
- Enrollment18
- Start date2015-02
- ConditionsMalignant Glioma · Myelosuppression
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.